Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 536

1.

Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues.

Seifi-Alan M, Shams R, Bandehpour M, Mirfakhraie R, Ghafouri-Fard S.

Cancer Manag Res. 2018 Jul 11;10:1969-1974. doi: 10.2147/CMAR.S169533. eCollection 2018.

PMID:
30022855
2.

Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma.

Wang WP, Li N, Zhang YY, Gao YT, Sun YC, Ge L, Wu LY.

Cancer Manag Res. 2018 Jul 10;10:1959-1968. doi: 10.2147/CMAR.S166524. eCollection 2018.

PMID:
30022854
3.

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma.

Chen H, Zhang Y, Li S, Li N, Chen Y, Zhang B, Qu C, Ding H, Huang J, Dai M.

Cancer Manag Res. 2018 Jul 10;10:1947-1958. doi: 10.2147/CMAR.S167036. eCollection 2018.

PMID:
30022853
4.

The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma.

Yu Y, Ke L, Lv X, Ling YH, Lu J, Liang H, Qiu W, Huang X, Liu G, Li W, Guo X, Xia W, Xiang Y.

Cancer Manag Res. 2018 Jul 9;10:1935-1946. doi: 10.2147/CMAR.S167071. eCollection 2018.

PMID:
30022852
5.

Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study.

Hu C, Jiang J, Li Y, Zhang C, Zhang W, Jiang H, Gao Y, Zhuang W, Lei K, Tang Y, Wan R.

Cancer Manag Res. 2018 Jul 6;10:1927-1934. doi: 10.2147/CMAR.S166930. eCollection 2018.

6.

Prognostic significance of Ki67 expression and the derived neutrophil-lymphocyte ratio in nasopharyngeal carcinoma.

Zhao L, Chen H, Hu B, Zhang H, Lin Q.

Cancer Manag Res. 2018 Jul 5;10:1919-1926. doi: 10.2147/CMAR.S167626. eCollection 2018.

7.

Benefit from the inclusion of surgery in the treatment of patients with stage III pancreatic cancer: a propensity-adjusted, population-based SEER analysis.

Wang L, Cheng CS, Chen L, Chen Z.

Cancer Manag Res. 2018 Jul 5;10:1907-1918. doi: 10.2147/CMAR.S167103. eCollection 2018.

8.

Safety and efficacy of denosumab in the treatment of pulmonary metastatic giant cell tumor of bone.

Luo Y, Tang F, Wang Y, Zhou Y, Min L, Zhang W, Shi R, Duan H, Tu C.

Cancer Manag Res. 2018 Jul 5;10:1901-1906. doi: 10.2147/CMAR.S161871. eCollection 2018.

9.

Modern management for brain metastasis patients using stereotactic radiosurgery: literature review and the authors' gamma knife treatment experiences.

Higuchi Y, Yamamoto M, Serizawa T, Aiyama H, Sato Y, Barfod BE.

Cancer Manag Res. 2018 Jul 5;10:1889-1899. doi: 10.2147/CMAR.S116718. eCollection 2018. Review.

10.

Prognostic and predictive value of the macroscopic growth pattern in patients undergoing curative resection of colorectal cancer: a single-institution retrospective cohort study of 4,080 Chinese patients.

Li X, Zhao Q, An B, Qi J, Wang W, Zhang D, Li Z, Qin C.

Cancer Manag Res. 2018 Jul 4;10:1875-1887. doi: 10.2147/CMAR.S165279. eCollection 2018.

11.

The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance.

Okazaki M, Fushida S, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Ninomiya I, Harada S, Ohta T.

Cancer Manag Res. 2018 Jul 4;10:1865-1874. doi: 10.2147/CMAR.S166136. eCollection 2018.

12.

Clinical usefulness of 18F-FDG PET/CT for the detection of distant metastases in patients with non-small cell lung cancer at initial staging: a meta-analysis.

Yu B, Zhu X, Liang Z, Sun Y, Zhao W, Chen K.

Cancer Manag Res. 2018 Jul 4;10:1859-1864. doi: 10.2147/CMAR.S155542. eCollection 2018. Review.

13.

Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists.

Gilmore J, D'Amato S, Griffith N, Schwartzberg L.

Cancer Manag Res. 2018 Jul 3;10:1827-1857. doi: 10.2147/CMAR.S166912. eCollection 2018. Review.

14.

CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case-control study.

Yang P, Wang M, Tian T, Feng Y, Zheng Y, Yang T, Li H, Lin S, Xu P, Deng Y, Hao Q, Li N, Guan F, Dai Z.

Cancer Manag Res. 2018 Jul 3;10:1791-1798. doi: 10.2147/CMAR.S167503. eCollection 2018.

15.

Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways.

Chen W, You J, Zheng Q, Zhu YY.

Cancer Manag Res. 2018 Jul 2;10:1817-1826. doi: 10.2147/CMAR.S164911. eCollection 2018.

16.

Polymorphisms in MYCN gene and neuroblastoma risk in Chinese children: a 3-center case-control study.

Zhou H, Zhuo Z, Chen S, Zhao J, Mo Y, Zhang J, He J, Ruan J.

Cancer Manag Res. 2018 Jul 2;10:1807-1816. doi: 10.2147/CMAR.S168515. eCollection 2018.

17.

Prognostic significance of the long noncoding RNAs in nasopharyngeal carcinoma: a systematic review and meta-analysis.

Guo H, Huang S, Li S, Yu H, Wu S, Zhou X.

Cancer Manag Res. 2018 Jun 27;10:1763-1779. doi: 10.2147/CMAR.S164695. eCollection 2018. Review.

18.

High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer.

Dai L, Pan G, Liu X, Huang J, Jiang Z, Zhu X, Gan X, Xu Q, Tan N.

Cancer Manag Res. 2018 Jun 29;10:1799-1806. doi: 10.2147/CMAR.S157925. eCollection 2018.

19.

Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma.

Xiao YB, Cai SH, Liu LL, Yang X, Yun JP.

Cancer Manag Res. 2018 Jun 26;10:1781-1789. doi: 10.2147/CMAR.S166971. eCollection 2018.

20.

A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease.

Liu C, Sun B, Xu B, Meng X, Li L, Cong Y, Liu J, Wang Q, Xuan L, Song Q, Wu S.

Cancer Manag Res. 2018 Jun 26;10:1749-1761. doi: 10.2147/CMAR.S160452. eCollection 2018.

Supplemental Content

Loading ...
Support Center